BRIVIACT: New Drug Trials Snapshot Posted

A new DRUG TRIALS SNAPSHOT FOR BRIVIACT is now available.

BRIVIACT is a drug for the treatment of specific type of seizures called partial-onset seizures in patients 16 years of age and older with epilepsy. Epilepsy is a brain disorder that causes people to have recurring seizures. BRIVIACT is to be used in combination with other anti-epileptic drugs that treat the same type of seizures.

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.